go back

Idecabtagene Vicleucel (Abecma), up to 460 Million Cells

Florida rates for HCPCS C9081

Idecabtagene vicleucel, up to 460 million autologous anti-BCMA CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $426,580 · 10th–90th $426,580$426,5800%50%100%$426,580Professionalmedian $426,580 · 10th–90th $426,580$426,5800%50%$426,580$500.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
AvMed
Setting
Facility
Modifier
Global
Typical Low
$426,579.52
Median
$426,579.52
Typical High
$426,579.52
AvMed
Setting
Professional
Modifier
Global
Typical Low
$426,579.52
Median
$426,579.52
Typical High
$426,579.52
United
Setting
Professional
Modifier
Global
Typical Low
$501,187.23
Median
$501,187.23
Typical High
$501,187.23